Matches in Wikidata for { <http://www.wikidata.org/entity/Q66065455> ?p ?o ?g. }
Showing items 1 to 39 of
39
with 100 items per page.
- Q66065455 description "clinical trial" @default.
- Q66065455 description "ensayu clínicu" @default.
- Q66065455 description "klinisch onderzoek" @default.
- Q66065455 description "клінічне випробування" @default.
- Q66065455 name "A Study of Dostarlimab (TSR-042) Plus Carboplatin-paclitaxel Versus Placebo Plus Carboplatin-paclitaxel in Patients With Recurrent or Primary Advanced Endometrial Cancer" @default.
- Q66065455 name "A Study of Dostarlimab" @default.
- Q66065455 type Item @default.
- Q66065455 label "A Study of Dostarlimab (TSR-042) Plus Carboplatin-paclitaxel Versus Placebo Plus Carboplatin-paclitaxel in Patients With Recurrent or Primary Advanced Endometrial Cancer" @default.
- Q66065455 label "A Study of Dostarlimab" @default.
- Q66065455 prefLabel "A Study of Dostarlimab (TSR-042) Plus Carboplatin-paclitaxel Versus Placebo Plus Carboplatin-paclitaxel in Patients With Recurrent or Primary Advanced Endometrial Cancer" @default.
- Q66065455 prefLabel "A Study of Dostarlimab" @default.
- Q66065455 P1132 Q66065455-C1B939D2-47B9-4C4D-939D-BCD135A4E307 @default.
- Q66065455 P1476 Q66065455-9611A8B9-981E-470B-BC06-72876A8707D5 @default.
- Q66065455 P1813 Q66065455-FE8E25CF-C711-4F06-8F19-3C00116B54AE @default.
- Q66065455 P2899 Q66065455-2530EA9C-4917-40BA-85CB-6C05F29B9C58 @default.
- Q66065455 P3098 Q66065455-97169D5E-2244-4C21-889D-E99FF53985C4 @default.
- Q66065455 P31 Q66065455-283A9E72-0B64-4469-A50C-77092F0A0B2F @default.
- Q66065455 P4844 Q66065455-08F74A16-AE86-44A4-91D7-0E63943982B0 @default.
- Q66065455 P4844 Q66065455-80D24B71-7242-4806-9360-65C2403299FD @default.
- Q66065455 P580 Q66065455-F92ED435-E6CC-47B3-8FA8-330051C6DED6 @default.
- Q66065455 P582 Q66065455-2F8AC6FE-961D-4431-BADB-E9D96143E19B @default.
- Q66065455 P6099 Q66065455-D1CC3069-D0C6-4901-8FED-35CEEA2435BE @default.
- Q66065455 P6153 Q66065455-F2E8C87C-51D7-4F7D-AA4A-437817B04C74 @default.
- Q66065455 P767 Q66065455-11410FD6-9A0A-4957-B028-5B2059326A3F @default.
- Q66065455 P8363 Q66065455-039A678A-48C8-456C-BD99-E1211E745578 @default.
- Q66065455 P1132 "+470" @default.
- Q66065455 P1476 "A Phase 3, Randomized, Double-blind, Multicenter Study of Dostarlimab (TSR-042) Plus Carboplatin-paclitaxel Versus Placebo Plus Carboplatin-paclitaxel in Patients With Recurrent or Primary Advanced Endometrial Cancer" @default.
- Q66065455 P1813 "RUBY" @default.
- Q66065455 P2899 "+18" @default.
- Q66065455 P3098 "NCT03981796" @default.
- Q66065455 P31 Q30612 @default.
- Q66065455 P4844 Q415588 @default.
- Q66065455 P4844 Q423762 @default.
- Q66065455 P580 "2019-07-15T00:00:00Z" @default.
- Q66065455 P582 "2021-11-26T00:00:00Z" @default.
- Q66065455 P6099 Q42824827 @default.
- Q66065455 P6153 Q212322 @default.
- Q66065455 P767 Q5625184 @default.
- Q66065455 P8363 Q78089383 @default.